- $1.67bn
- $3.35bn
- $1.55bn
- 26
- 97
- 30
- 49
2019 December 31st | C2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 837 | 677 | 1,394 | 1,921 | 1,548 |
Cost of Revenue | |||||
Gross Profit | 553 | 317 | 924 | 1,460 | 1,135 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,204 | 1,530 | 681 | 862 | 992 |
Operating Profit | -367 | -853 | 713 | 1,059 | 556 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -345 | -878 | 149 | 637 | 512 |
Provision for Income Taxes | |||||
Net Income After Taxes | -342 | -874 | 145 | 632 | 695 |
Net Income Before Extraordinary Items | |||||
Net Income | -342 | -874 | 145 | 632 | 695 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -342 | -874 | 145 | 632 | 695 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.88 | -25.1 | 5.09 | 38.2 | 33.6 |